These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 20018528)

  • 1. Cancer informatics for the clinician: an interaction database for chemotherapy regimens and antiepileptic drugs.
    Yap KY; Chan A; Chui WK; Chen YZ
    Seizure; 2010 Jan; 19(1):59-67. PubMed ID: 20018528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a chemotherapy regimen interaction database for the mobile internet: detecting interactions with psychotropics through OncoRx-MI.
    Yap KY; Chui WK; Chan A;
    Inform Health Soc Care; 2011 Sep; 36(3):132-46. PubMed ID: 21848450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug interactions between chemotherapeutic regimens and antiepileptics.
    Yap KY; Chui WK; Chan A
    Clin Ther; 2008 Aug; 30(8):1385-407. PubMed ID: 18803983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harnessing the internet cloud for managing drug interactions with chemotherapy regimens in patients with cancer suffering from depression.
    Yap KY; Ho YX; Chui WK; Chan A
    Acta Oncol; 2010 Nov; 49(8):1235-45. PubMed ID: 20515422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An onco-informatics database for anticancer drug interactions with complementary and alternative medicines used in cancer treatment and supportive care: an overview of the OncoRx project.
    Yap KY; Kuo EY; Lee JJ; Chui WK; Chan A
    Support Care Cancer; 2010 Jul; 18(7):883-91. PubMed ID: 19756775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilizing mobile networks for the detection of clinically relevant interactions between chemotherapy regimens and complementary and alternative medicines.
    Yap KY; See CS; Kuo EY; Chui WK; Chan A
    J Altern Complement Med; 2012 Feb; 18(2):165-74. PubMed ID: 22320169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electronic database to detect drug-drug interactions between antidepressants and oral anticancer drugs from a cancer center in Singapore: implications to clinicians.
    Chan A; Yap KY; Koh D; Low XH; Cheung YT;
    Pharmacoepidemiol Drug Saf; 2011 Sep; 20(9):939-47. PubMed ID: 21732473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinically relevant drug interactions between anticancer drugs and psychotropic agents.
    Yap KY; Tay WL; Chui WK; Chan A
    Eur J Cancer Care (Engl); 2011 Jan; 20(1):6-32. PubMed ID: 20030690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concomitant drugs with low risks of drug-drug interactions for use in oncology clinical trials.
    Ranchon F; Vial T; Rioufol C; Hénin E; Falandry C; Freyer G; Trillet-Lenoir V; Le Tourneau C; You B
    Crit Rev Oncol Hematol; 2015 May; 94(2):189-200. PubMed ID: 25638703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinically-relevant anticancer-antidepressant drug interactions.
    Chan A; Ng TR; Yap KY
    Expert Opin Drug Metab Toxicol; 2012 Feb; 8(2):173-99. PubMed ID: 22191471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment patterns in patients with advanced breast cancer who were exposed to an anthracycline, a taxane, and capecitabine: a descriptive report.
    Donato BM; Burns L; Willey V; Cohenuram M; Oliveria S; Yood MU
    Clin Ther; 2010 Mar; 32(3):546-54. PubMed ID: 20399992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies.
    Shih T; Lindley C
    Clin Ther; 2006 Nov; 28(11):1779-802. PubMed ID: 17212999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concomitant therapy in people with epilepsy: potential drug-drug interactions and patient awareness.
    Eyal S; Rasaby S; Ekstein D
    Epilepsy Behav; 2014 Feb; 31():369-76. PubMed ID: 24211058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of nuclear receptors in pharmacokinetic drug-drug interactions in oncology.
    Harmsen S; Meijerman I; Beijnen JH; Schellens JH
    Cancer Treat Rev; 2007 Jun; 33(4):369-80. PubMed ID: 17451886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing pharmacokinetic and pharmacodynamic interactions in clinical trials of antiepileptic drugs.
    Reife RA
    Adv Neurol; 1998; 76():95-103. PubMed ID: 9408466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Choice of antiepileptic drugs for the elderly: possible drug interactions and adverse effects.
    Jankovic SM; Dostic M
    Expert Opin Drug Metab Toxicol; 2012 Jan; 8(1):81-91. PubMed ID: 22175232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical therapy of advanced malignant epithelial tumours of the ovary.
    Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A
    Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anemia and thrombocytopenia in patients undergoing chemotherapy for solid tumors: a descriptive study of a large outpatient oncology practice database, 2000-2007.
    Wu Y; Aravind S; Ranganathan G; Martin A; Nalysnyk L
    Clin Ther; 2009; 31 Pt 2():2416-32. PubMed ID: 20110050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-drug interactions in pediatric oncology patients.
    Balk TE; van der Sijs IH; van Gelder T; Janssen JJB; van der Sluis IM; van Leeuwen RWF; Engels FK
    Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 28205376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of the coprescription of clinically important interacting drug combinations involving oral anticancer agents in Singapore: a retrospective database study.
    Ko Y; Tan SL; Chan A; Wong YP; Yong WP; Ng RC; Lim SW; Salim A
    Clin Ther; 2012 Aug; 34(8):1696-704. PubMed ID: 22795926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.